|
시장보고서
상품코드
2024636
안과용 점탄성 디바이스 시장 규모 : 제품별, 용도별, 최종사용자별, 지역별(2026-2034년)Ophthalmic Viscoelastic Devices Market Size by Product, Application, End User, and Region 2026-2034 |
||||||
세계의 안과용 점탄성 디바이스(OVD) 시장 규모는 2025년에 29억 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 39억 달러에 달하며, 2026-2034년에 CAGR 3.21%로 성장할 것으로 예측하고 있습니다. 안과 수술 건수의 증가, 활발한 연구개발(R&D) 활동, 의료 산업의 급격한 성장은 시장을 촉진하는 주요 요인 중 일부입니다.
안과용 점탄성 장치(OVD)는 안과 수술시 사용되는 의료기기입니다. 녹내장, 각막이식, 유리체 망막 수술, 백내장 수술 등 안과 및 수많은 안과 수술에 사용되고 있습니다. 이 장치는 기계적 손상으로부터 눈의 구조를 보호하고, 조직을 분리하고, 공간을 만들고, 유착을 제거하고, 습윤제 역할을 하며, 수술 절차를 원활하게 하기 위한 툴로 작용합니다. OVD는 인공수정체(IOL) 삽입시 안구내 공간을 유지하고, 전방의 안정화 및 심화를 도모하며, 전안부 수술시 안구 구조를 보호하기 위해 널리 사용되고 있습니다. 이 장치는 전방내 압력을 생성하고, 안구 내를 구획화하여 환자의 회복을 돕고, 보다 빠르고 안전한 수술을 실현하는 데 도움이 됩니다.
안과용 점탄성 디바이스(OVD) 시장 동향:
전 세계에서 안과 수술 건수가 증가하고 있는 것이 시장 성장을 이끄는 주요 요인 중 하나입니다. OVD는 공간 유지 및 확보, 조직 변위, 안정화 및 보호를 위해 널리 사용됩니다. 이에 따라 안과 의료 시설에 대한 접근성 향상과 안질환에 대한 인식이 높아진 것도 시장 성장을 촉진하는 요인으로 작용하고 있습니다. 또한 복잡한 안과 수술 사례의 증가와 함께 점탄성 적응형 안과용 점탄성 장치의 사용이 확산되고 있으며, 주사기 두 개가 필요 없다는 이중적인 장점이 시장 성장을 촉진하고 있습니다. 이 외에도 소아 백내장 수술, 플로피 홍채 증후군 환자, 외상, 플루크스 각막이상증과 같은 복잡한 안과 수술에서도 수술 후 합병증을 피하기 위해 점탄성 OVD가 선호되고 있으며, 이는 시장 성장을 촉진하고 있습니다. 이와는 별도로, 수술 중 동시에 사용할 수 있고, 비용 효율적이며, 품질 기준을 보장하고, 안과 의사의 업무 부담을 줄여주는 응집성 OVD와 분산성 OVD를 단일 유닛에 담은 복합 패키지의 도입은 시장 성장에 탄력을 받고 있습니다. 또한 고령 인구의 증가와 당뇨병 및 노화에 따른 안질환의 유병률 증가도 시장 성장에 긍정적인 영향을 미치고 있습니다. 이 외에도 소비자의 구매력 향상, 활발한 연구개발(R&D) 활동, 의료산업의 괄목할 만한 성장, 그리고 시력장애 증가를 억제하기 위해 제조업체에 새로운 안과용 기기 도입을 의무화하는 등 정부의 다양한 정책 시행 등이 시장 전망을 밝게 하고 있습니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 안과용 점탄성 디바이스 시장
제6장 시장 내역 : 제품별
제7장 시장 내역 : 용도별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
제10장 촉진요인·억제요인·기회
제11장 밸류체인 분석
제12장 Porters Five Forces 분석
제13장 가격 분석
제14장 경쟁 구도
KSA 26.05.18The global ophthalmic viscoelastic devices (OVD) market size reached USD 2.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.21% during 2026-2034. The increasing number of ophthalmic surgeries, extensive research and development (R&D) activities, and escalating growth in the healthcare industry represent some of the key factors driving the market.
Ophthalmic viscoelastic devices (OVD) are medical equipment used during eye surgeries. They are employed in ophthalmic and numerous eye surgeries, such as glaucoma, corneal transplant, and vitreoretinal and cataract surgery. These devices protect ocular structures from mechanical trauma, divide tissue, create space, resolve adhesions, act as a wetting agent, or as an instrument to facilitate the surgical procedure. OVDs are widely used to maintain space in the eye during intraocular lens (IOL) implantation, stabilize and deepen the anterior chamber, and protect ocular structures during anterior segment surgery. These devices assist in creating pressure within the anterior chamber, compartmentalizing inside the attention, and providing a faster and safer surgery with better recovery for the patients.
Ophthalmic Viscoelastic Devices (OVD) Market Trends:
The increasing number of ophthalmic surgeries across the globe is one of the key factors driving the market growth. OVDs are widely used to maintain, preserve space, displace, stabilize, and protect tissues. In line with this, improving access to ophthalmic care facilities and rising awareness about ocular disorders are acting as another growth-inducing factor. Moreover, the widespread utilization of viscoadaptive ophthalmic viscosurgical devices due to the increasing number of complex ocular surgical cases and its biphasic benefit of eliminating the need for two syringes is propelling the market growth. In addition to this, viscoadaptive OVD is also preferred in complex ocular surgeries, such as pediatric cataract surgery, patient with floppy iris syndrome, trauma, Fuchs dystrophy, and other cases to avoid post-surgical complications, which, in turn, is favoring the market growth. Apart from this, the introduction of a combination package of cohesive and dispersive OVD contained in a single unit, that is used simultaneously during procedures and is cost-effective, ensures quality standards and eases out ophthalmic surgeons' activities is providing an impetus to the market growth. Additionally, the rising geriatric population and the increasing prevalence of diabetes and age-related ocular disorders are positively influencing the market growth. Other factors, including the rising expenditure capacities of consumers, extensive research and development (R&D) activities, significant expansion in the healthcare industry, and the implementation of various government initiatives to control the rising vision impairment by compelling producers to introduce new ophthalmic equipment, are creating a positive outlook for the market.
Key Market Segmentation:
This report provides an analysis of the key trends in each segment of the global ophthalmic viscoelastic devices (OVD) market, along with forecasts at the global, regional, and country level from 2026-2034. The report has categorized the market based on product, application, and end user.
Product Insights:
- Cohesive Ophthalmic Viscoelastic
- Dispersive Ophthalmic Viscoelastic
Application Insights:
- Cataract Surgery
- Glaucoma Surgery
- Corneal Transplant
- Vitreoretinal Surgery
End User Insights:
- Hospitals
- Ophthalmic Clinics
- Others
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for ophthalmic viscoelastic devices (OVD). Some of the factors driving the North America ophthalmic viscoelastic devices (OVD) market included extensive research and development (R&D) activities, the rising geriatric population, and the increasing prevalence of diabetes and age-related ocular disorders.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global ophthalmic viscoelastic devices (OVD) market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Alcon Inc., Altacor Limited, Bausch Health Companies Inc., Bohus Biotech Ab, Carl Zeiss Meditec Ag, Cima Technology Inc, Eyekon Medical Inc., Johnson & Johnson, RUMEX International Co., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global Ophthalmic Viscoelastic Devices (OVD) market in 2025?
2. What is the expected growth rate of the global Ophthalmic Viscoelastic Devices (OVD) market during 2026-2034?
3. What are the key factors driving the global Ophthalmic Viscoelastic Devices (OVD) market?
4. What has been the impact of COVID-19 on the global Ophthalmic Viscoelastic Devices (OVD) market?
5. What is the breakup of the global Ophthalmic Viscoelastic Devices (OVD) market based on the product?
6. What is the breakup of the global Ophthalmic Viscoelastic Devices (OVD) market based on the application?
7. What is the breakup of the global Ophthalmic Viscoelastic Devices (OVD) market based on the end user?
8. What are the key regions in the global Ophthalmic Viscoelastic Devices (OVD) market?
9. Who are the key players/companies in the global Ophthalmic Viscoelastic Devices (OVD) market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Ophthalmic Viscoelastic Devices (OVD) Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Cohesive Ophthalmic Viscoelastic
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Dispersive Ophthalmic Viscoelastic
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Application
- 7.1 Cataract Surgery
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Glaucoma Surgery
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Corneal Transplant
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Vitreoretinal Surgery
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ophthalmic Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.1.1 United States
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.2.1 China
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.3.1 Germany
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.4.1 Brazil
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
- 10.1 Overview
- 10.2 Drivers
- 10.3 Restraints
- 10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Alcon Inc.
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.2 Altacor Limited
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Bausch Health Companies Inc.
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Bohus Biotech Ab
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.5 Carl Zeiss Meditec Ag
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 Cima Technology Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.7 Eyekon Medical Inc.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.8 Johnson & Johnson
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 RUMEX International Co.
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.1 Alcon Inc.
